Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 42,300
-250 (-0.59%)
At close: Sep 17, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 617.58 billion as of September 16, 2026.
Market Cap
617.58B
Enterprise Value
148.56B
Revenue
293.03B
Ranking
n/a
PE Ratio
6.58
Stock Price
42,300.00
ChartMarket Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 617.58B, a decrease of -65.30%. That is a compound annual growth rate of -66.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 617.58B | -38.61% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.29T |
| Celltrion | 42.60T |
| ALTEOGEN | 18.10T |
| Samsung Epis Holdings | 8.27T |
| Onconic Therapeutics | 667.50B |
| Pharmicell | 651.64B |
| Dong-A Socio Holdings | 635.30B |
| Lunit | 635.13B |